Can subtle changes in gene expression be consistently detected with different microarray platforms?
Authors:
- Paola PedottiPPPaola Pedotti
- Peter Ac 'T HoenPHPeter Ac 'T Hoen
- Erno VreugdenhilEVErno Vreugdenhil
- Geert J SchenkGSGeert J Schenk
- Rolf Ham VossenRVRolf Ham Vossen
- Yavuz AriyurekYAYavuz Ariyurek
- Mattias de HollanderMHMattias de Hollander
- Rowan KuiperRKRowan Kuiper
- Gertjan Jb van OmmenGOGertjan Jb van Ommen
- Johan T Den DunnenJDJohan T Den Dunnen
- Judith M BoerJBJudith M Boer
- Renée X de MenezesRMRenée X de Menezes
Open Access
- 10 March 2008
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 9 (1) , 124
Abstract
Background: The comparability of gene expression data generated with different microarray platforms is still a matter of concern. Here we address the performance and the overlap in the detection of differentially expressed genes for five different microarray platforms in a challenging biological context where differences in gene expression are few and subtle.Results: Gene expression profiles in the hippocampus of five wild-type and five transgenic δC-doublecortin-like kinase mice were evaluated with five microarray platforms: Applied Biosystems, Affymetrix, Agilent, Illumina, LGTC home-spotted arrays. Using a fixed false discovery rate of 10% we detected surprising differences between the number of differentially expressed genes per platform. Four genes were selected by ABI, 130 by Affymetrix, 3,051 by Agilent, 54 by Illumina, and 13 by LGTC. Two genes were found significantly differentially expressed by all platforms and the four genes identified by the ABI platform were found by at least three other platforms. Quantitative RT-PCR analysis confirmed 20 out of 28 of the genes detected by two or more platforms and 8 out of 15 of the genes detected by Agilent only. We observed improved correlations between platforms when ranking the genes based on the significance level than with a fixed statistical cut-off. We demonstrate significant overlap in the affected gene sets identified by the different platforms, although biological processes were represented by only partially overlapping sets of genes. Aberrances in GABA-ergic signalling in the transgenic mice were consistently found by all platforms.Conclusion: The different microarray platforms give partially complementary views on biological processes affected. Our data indicate that when analyzing samples with only subtle differences in gene expression the use of two different platforms might be more attractive than increasing the number of replicates. Commercial two-color platforms seem to have higher power for finding differentially expressed genes between groups with small differences in expression.Keywords
This publication has 56 references indexed in Scilit:
- GABA sets the tempo for activity-dependent adult neurogenesisTrends in Neurosciences, 2007
- Using RNA sample titrations to assess microarray platform performance and normalization techniquesNature Biotechnology, 2006
- The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurementsNature Biotechnology, 2006
- Evaluation of DNA microarray results with quantitative gene expression platformsNature Biotechnology, 2006
- Thousands of samples are needed to generate a robust gene list for predicting outcome in cancerProceedings of the National Academy of Sciences, 2006
- GABAergic Excitation Promotes Neuronal Differentiation in Adult Hippocampal Progenitor CellsNeuron, 2005
- Microarray reality checks in the context of a complex diseaseNature Biotechnology, 2004
- Evaluation of gene expression measurements from commercial microarray platformsNucleic Acids Research, 2003
- A Stem Cell Molecular SignatureScience, 2002
- "Stemness": Transcriptional Profiling of Embryonic and Adult Stem CellsScience, 2002